A carregar...
BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53
The acquisition of drug resistance is a persistent clinical problem limiting the successful treatment of glioblastoma (GBM). However, the molecular mechanisms by which initially chemoresponsive tumors develop therapeutic resistance remain poorly understood. In this study, we report that BACH1, a hem...
Na minha lista:
Publicado no: | Sci Rep |
---|---|
Main Authors: | , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Nature Publishing Group
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5175153/ https://ncbi.nlm.nih.gov/pubmed/28000777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep39743 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|